Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma

Non-neuronal cholinergic system (NNCS) contributes to various inflammatory airway diseases. However, the role of NNCS in severe asthma (SA) remains largely unexplored. To explore airway NNCS in SA. In this prospective cohort study based on the Australasian Severe Asthma Network in a real-world setti...

Full description

Saved in:
Bibliographic Details
Published inAnnals of allergy, asthma, & immunology Vol. 133; no. 1; pp. 64 - 72.e4
Main Authors Huang, Dan, Zhang, Li, Liu, Ying, Wang, Ji, Zhang, Jie, Baines, Katherine J., Liu, Gang, Hsu, Alan Chen-Yu, Wang, Fang, Chen, Zhihong, Oliver, Brian G., Xie, Min, Qin, Ling, Liu, Dan, Wan, Huajing, Luo, Fengming, Li, Weimin, Wang, Gang, Gibson, Peter G.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2024
Online AccessGet full text

Cover

Loading…
More Information
Summary:Non-neuronal cholinergic system (NNCS) contributes to various inflammatory airway diseases. However, the role of NNCS in severe asthma (SA) remains largely unexplored. To explore airway NNCS in SA. In this prospective cohort study based on the Australasian Severe Asthma Network in a real-world setting, patients with SA (n = 52) and non-SA (n = 104) underwent clinical assessment and sputum induction. The messenger RNA (mRNA) levels of NNCS components and proinflammatory cytokines in the sputum were detected using real-time quantitative polymerase chain reaction, and the concentrations of acetylcholine (Ach)-related metabolites were evaluated using liquid chromatography coupled with tandem mass spectrometry. Asthma exacerbations were prospectively investigated during the next 12 months. The association between NNCS and future asthma exacerbations was also analyzed. Patients with SA were less controlled and had worse airway obstruction, a lower bronchodilator response, higher doses of inhaled corticosteroids, and more add-on treatments. The sputum mRNA levels of NNCS components, such as muscarinic receptors M1R-M5R, OCT3, VACHT, and ACHE; proinflammatory cytokines; and Ach concentration in the SA group were significantly higher than those in the non-SA group. Furthermore, most NNCS components positively correlated with non-type (T) 2 inflammatory profiles, such as sputum neutrophils, IL8, and IL1B. In addition, the mRNA levels of sputum M2R, M3R, M4R, M5R, and VACHT were independently associated with an increased risk of moderate-to-severe asthma exacerbations. This study indicated that the NNCS was significantly activated in SA, leading to elevated Ach and was associated with clinical features, non-T2 inflammation, and future exacerbations of asthma, highlighting the potential role of the NNCS in the pathogenesis of SA. ChiCTR-OOC-16009529 (http://www.chictr.org.cn).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1081-1206
1534-4436
1534-4436
DOI:10.1016/j.anai.2024.03.009